Barclays PLC Pacific Biosciences Of California, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Barclays PLC holds 595,150 shares of PACB stock, worth $928,434. This represents 0.0% of its overall portfolio holdings.

Number of Shares

595,150

Previous 595,150 -0.0%

Holding current value

$928,434

Previous $1.01 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$1.2 - $2.17 $420,235 - $759,925	350,196 Added 142.96%	595,150 $1.01 Million
Q2 2024 Aug 14, 2024	SELL	$1.36 - $3.65 $571,367 - $1.53 Million	-420,123 Reduced 63.17%	244,954 $336,000
Q1 2024 May 15, 2024	BUY	$3.52 - $9.59 $701,279 - $1.91 Million	199,227 Added 42.77%	665,077 $2.49 Million
Q4 2023 Feb 15, 2024	BUY	$5.97 - $10.36 $2.05 Million - $3.56 Million	344,041 Added 282.44%	465,850 $4.57 Million
Q3 2023 Nov 07, 2023	SELL	$8.23 - $13.93 $1.56 Million - $2.64 Million	-189,547 Reduced 60.88%	121,809 $1.02 Million
Q2 2023 Aug 03, 2023	BUY	$9.97 - $14.05 $1.56 Million - $2.19 Million	156,177 Added 100.64%	311,356 $4.14 Million
Q1 2023 May 04, 2023	BUY	$7.94 - $12.02 $223,995 - $339,096	28,211 Added 22.22%	155,179 $1.8 Million
Q4 2022 Feb 13, 2023	BUY	$5.67 - $11.2 $196,612 - $388,371	34,676 Added 37.57%	126,968 $1.04 Million
Q3 2022 Nov 03, 2022	SELL	$3.93 - $8.57 $342,035 - $745,864	-87,032 Reduced 48.53%	92,292 $536,000
Q2 2022 Aug 12, 2022	BUY	$4.02 - $10.43 $74,410 - $193,059	18,510 Added 11.51%	179,324 $792,000
Q1 2022 May 16, 2022	SELL	$8.43 - $20.9 $1.33 Million - $3.3 Million	-157,996 Reduced 49.56%	160,814 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$19.26 - $30.08 $3.98 Million - $6.21 Million	206,485 Added 183.83%	318,810 $6.52 Million
Q3 2021 Nov 09, 2021	BUY	$24.86 - $35.02 $1.32 Million - $1.86 Million	53,157 Added 89.84%	112,325 $2.87 Million
Q2 2021 Aug 13, 2021	SELL	$22.3 - $36.02 $2.84 Million - $4.58 Million	-127,189 Reduced 68.25%	59,168 $2.07 Million
Q1 2021 May 13, 2021	BUY	$26.38 - $51.15 $3.35 Million - $6.5 Million	127,143 Added 214.72%	186,357 $6.21 Million
Q4 2020 Feb 11, 2021	SELL	$10.5 - $28.5 $184,705 - $501,343	-17,591 Reduced 22.9%	59,214 $1.54 Million
Q3 2020 Nov 12, 2020	SELL	$3.61 - $9.87 $173,731 - $474,993	-48,125 Reduced 38.52%	76,805 $758,000
Q2 2020 Aug 12, 2020	BUY	$2.65 - $4.03 $131,164 - $199,468	49,496 Added 65.61%	124,930 $431,000
Q1 2020 May 13, 2020	SELL	$2.36 - $5.26 $1.6 Million - $3.57 Million	-679,483 Reduced 90.01%	75,434 $231,000
Q4 2019 Feb 10, 2020	BUY	$4.6 - $5.57 $916,885 - $1.11 Million	199,323 Added 35.88%	754,917 $3.88 Million
Q3 2019 Nov 14, 2019	BUY	$4.99 - $6.16 $1.34 Million - $1.65 Million	267,982 Added 93.17%	555,594 $2.87 Million
Q2 2019 Aug 14, 2019	SELL	$5.92 - $7.41 $401,500 - $502,553	-67,821 Reduced 19.08%	287,612 $1.74 Million
Q1 2019 May 15, 2019	SELL	$6.8 - $7.4 $1.65 Million - $1.8 Million	-243,122 Reduced 40.62%	355,433 $2.57 Million
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $1.77 Million - $3.48 Million	444,528 Added 288.6%	598,555 $4.43 Million
Q3 2018 Nov 14, 2018	BUY	$3.52 - $5.55 $369,441 - $582,500	104,955 Added 213.88%	154,027 $834,000
Q2 2018 Aug 14, 2018	BUY	$2.11 - $3.92 $34,833 - $64,715	16,509 Added 50.7%	49,072 $173,000
Q1 2018 May 15, 2018	SELL	$2.05 - $3.23 $142,833 - $225,050	-69,675 Reduced 68.15%	32,563 $67,000
Q4 2017 Feb 14, 2018	BUY	$2.59 - $5.44 $258,577 - $543,113	99,837 Added 4158.14%	102,238 $270,000
Q3 2017 Nov 14, 2017	BUY	$3.2 - $5.57 $7,683 - $13,373	2,401	2,401 $13,000

Others Institutions Holding PACB

# of Institutions

260

Shares Held

230M

Call Options Held

745K

Put Options Held

1.23M

View Full List

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $351M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

More about PACB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account